Ultragenyx Pharmaceutical Inc at Jefferies Healthcare Conference Transcript
My name is Maury Raycroft, and I'm one of the biotech analysts at Jefferies. I'm happy to introduce our guest today, Emil Kakkis, the CEO of Ultragenyx. Thanks a lot for joining us today, Emil.
Thanks for having me, Maury.
And we're going to do a fireside chat discussion. So for those who may be new to the story, can you provide a 1-minute overview of Ultragenyx, your commercial products and your pipeline?
Yes. Ultragenyx is a rare -- a company focused on rare and ultra-rare disease, has been in business 12 years. We're a commercial company with 4 approved products that we're commercializing in the U.S., Canada, Latin America, Europe and, most recently, beginning in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
